Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

Anti-tnfrsf10d Antibody scFv

DESCRIPTION CATALOG # SIZE PRICE
Recombinant Anti-Human tnfrsf10d Antibody scFv Fragment MOM-18513-S(P) 1mg Please Inquiry
Product Detail
Cat
MOM-18513-S(P)
Product Overview
Recombinant Mouse Antibody scFv Fragment is bind to Human TNFRSF10D, expressed in E. coli
Target
TNFRSF10D
Type
scFv
Immunogen
Recombinant human DcR2/Fc chimera
Species Reactivity
Human
Expression Host
E. coli
Applications
Suitable for use in ELISA, WB, Neut and most other immunological methods.
Specificity
Tested positive against native antigen.
Purity
>95%, by SDS-PAGE with silver staining, under reducing conditions.
Storage
At -20°C for one year.
Background
Antigen Description
Receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis but protects against TRAIL-mediated apoptosis. Reports are contradictory with regards to its ability to induce the NF-kappa-B pathway. According to PubMed:9382840, it cannot but according to PubMed:9430226, it can induce the NF-kappa-B pathway.
Function
TRAIL binding; binding; receptor activity; transmembrane signaling receptor activity;
Gene ID
8793
Synonyms
TNFRSF10D; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily member 10D; CD264; DcR2; TRAILR4; TRUNDD; TRAIL receptor 4; decoy receptor 2; decoy with truncated death domain; TNF receptor-related receptor for TRAIL; TRAIL receptor with a truncated death domain; TNF-related apoptosis-inducing ligand receptor 4; DCR2; TRAIL-R4
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


© 2007 - 2017 Creative-Biolabs All Rights Reserved